Cervel

Curated by Signal

Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression

Overview

Cervel Neurotech, (formerly NeoStim) is a privately held medical device company focused on non-invasive deep brain neuro-modulation for treatment-resistant depression. Cervel’s technology is a form of repetitive transcranial magnetic stimulation (rTMS) which uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas.

Key facts

Founded: 2008
Headquarters: Redwood City, United States
Stage: Sign up to view
Industry: Life Sciences Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Estroven
Provider of nutritional supplements for menopause relief
Life Sciences TechnologyCromwell, United States
Novela Neurotechnologies
Developer of neural implants to monitor, diagnose and treat the neurological disorders
Life Sciences TechnologyAlameda, United States
Harvest Connect
Developer of plant-based medicine and therapeutic psychedelics for general wellness and mental health
Life Sciences TechnologyRoswell, United States

About Cervel

What does Cervel do?

Cervel Neurotech, (formerly NeoStim) is a privately held medical device company focused on non-invasive deep brain neuro-modulation for treatment-resistant depression.

Where is Cervel headquartered?

Cervel is headquartered in Redwood City, United States.

When was Cervel founded?

Cervel was founded in 2008.

Which sector is Cervel in?

Cervel operates in Life Sciences Technology.

Who are Cervel's competitors?

Companies similar to Cervel include Estroven, Novela Neurotechnologies, and Harvest Connect.